世界の生物学的API医薬品製造市場2020-2025:社内製造、受託製造

LP Informationが発行した調査報告書(LPI20DE0509)
◆英語タイトル:Global Biological API Drug Manufacturing Market Growth 2020-2025
◆商品コード:LPI20DE0509
◆発行会社(リサーチ会社):LP Information
◆発行日:2020年12月(※2024年版があります。お問い合わせください。)
◆ページ数:159
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:化学、材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「生物学的API医薬品製造の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、社内製造、受託製造など、用途別には、モノクローナル抗体(mAb)療法、ワクチン、インスリン療法、インターフェロン療法、その他などに区分してまとめた調査レポートです。生物学的API医薬品製造のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・生物学的API医薬品製造の世界市場概要(サマリー)
・生物学的API医薬品製造の企業別販売量・売上
・生物学的API医薬品製造の企業別市場シェア
・生物学的API医薬品製造の世界市場規模 2015年-2020年:種類別(社内製造、受託製造)
・生物学的API医薬品製造の世界市場規模 2015年-2020年:用途別(モノクローナル抗体(mAb)療法、ワクチン、インスリン療法、インターフェロン療法、その他)
・生物学的API医薬品製造の米州市場規模(アメリカ、カナダ、メキシコなど)
・生物学的API医薬品製造のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・生物学的API医薬品製造の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・生物学的API医薬品製造の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・生物学的API医薬品製造市場の成長要因・課題・動向
・生物学的API医薬品製造の世界市場予測 2021年-2025年
・生物学的API医薬品製造の米州市場予測(アメリカ、カナダ、メキシコなど)
・生物学的API医薬品製造のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・生物学的API医薬品製造の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・生物学的API医薬品製造の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・生物学的API医薬品製造の世界市場予測:種類別(社内製造、受託製造)
・生物学的API医薬品製造の世界市場予測:用途別(モノクローナル抗体(mAb)療法、ワクチン、インスリン療法、インターフェロン療法、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Biological API Drug Manufacturing market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biological API Drug Manufacturing business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological API Drug Manufacturing market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Biological API Drug Manufacturing, covering the supply chain analysis, impact assessment to the Biological API Drug Manufacturing market size growth rate in several scenarios, and the measures to be undertaken by Biological API Drug Manufacturing companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
In-House manufacturing
Contract manufacturing
API contract manufacturing dominates the global biological API drug manufacturing market.

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Lonza
CEPiA Sanofi
Boehringer Ingelheim BioXcellence
DSM
Samsung BioLogics
Celltrion
AbbVie
Fujifilm Diosynth Biotechnologies
Baxter
Cytovance Biologics
GSK
Vetter
Sandoz
Wuxi Biologics
Pfizer CentreOne

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Biological API Drug Manufacturing consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Biological API Drug Manufacturing market by identifying its various subsegments.
Focuses on the key global Biological API Drug Manufacturing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biological API Drug Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biological API Drug Manufacturing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biological API Drug Manufacturing Consumption 2015-2025
2.1.2 Biological API Drug Manufacturing Consumption CAGR by Region
2.2 Biological API Drug Manufacturing Segment by Type
2.2.1 In-House manufacturing
2.2.2 Contract manufacturing
2.3 Biological API Drug Manufacturing Consumption by Type
2.3.1 Global Biological API Drug Manufacturing Consumption Market Share by Type (2015-2020)
2.3.2 Global Biological API Drug Manufacturing Revenue and Market Share by Type (2015-2020)
2.3.3 Global Biological API Drug Manufacturing Sale Price by Type (2015-2020)
2.4 Biological API Drug Manufacturing Segment by Application
2.4.1 Monoclonal Antibody (mAb) Therapies
2.4.2 Vaccines
2.4.3 Insulin Therapies
2.4.4 Interferon Therapies
2.4.5 Other
2.5 Biological API Drug Manufacturing Consumption by Application
2.5.1 Global Biological API Drug Manufacturing Consumption Market Share by Type (2015-2020)
2.5.2 Global Biological API Drug Manufacturing Value and Market Share by Type (2015-2020)
2.5.3 Global Biological API Drug Manufacturing Sale Price by Type (2015-2020)

3 Global Biological API Drug Manufacturing by Company
3.1 Global Biological API Drug Manufacturing Sales Market Share by Company
3.1.1 Global Biological API Drug Manufacturing Sales by Company (2018-2020)
3.1.2 Global Biological API Drug Manufacturing Sales Market Share by Company (2018-2020)
3.2 Global Biological API Drug Manufacturing Revenue Market Share by Company
3.2.1 Global Biological API Drug Manufacturing Revenue by Company (2018-2020)
3.2.2 Global Biological API Drug Manufacturing Revenue Market Share by Company (2018-2020)
3.3 Global Biological API Drug Manufacturing Sale Price by Company
3.4 Global Biological API Drug Manufacturing Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Biological API Drug Manufacturing Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Biological API Drug Manufacturing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biological API Drug Manufacturing by Regions
4.1 Biological API Drug Manufacturing by Regions
4.2 Americas Biological API Drug Manufacturing Consumption Growth
4.3 APAC Biological API Drug Manufacturing Consumption Growth
4.4 Europe Biological API Drug Manufacturing Consumption Growth
4.5 Middle East & Africa Biological API Drug Manufacturing Consumption Growth

5 Americas
5.1 Americas Biological API Drug Manufacturing Consumption by Countries
5.1.1 Americas Biological API Drug Manufacturing Consumption by Countries (2015-2020)
5.1.2 Americas Biological API Drug Manufacturing Value by Countries (2015-2020)
5.2 Americas Biological API Drug Manufacturing Consumption by Type
5.3 Americas Biological API Drug Manufacturing Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biological API Drug Manufacturing Consumption by Regions
6.1.1 APAC Biological API Drug Manufacturing Consumption by Regions (2015-2020)
6.1.2 APAC Biological API Drug Manufacturing Value by Regions (2015-2020)
6.2 APAC Biological API Drug Manufacturing Consumption by Type
6.3 APAC Biological API Drug Manufacturing Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Biological API Drug Manufacturing by Countries
7.1.1 Europe Biological API Drug Manufacturing Consumption by Countries (2015-2020)
7.1.2 Europe Biological API Drug Manufacturing Value by Countries (2015-2020)
7.2 Europe Biological API Drug Manufacturing Consumption by Type
7.3 Europe Biological API Drug Manufacturing Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Biological API Drug Manufacturing by Countries
8.1.1 Middle East & Africa Biological API Drug Manufacturing Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Biological API Drug Manufacturing Value by Countries (2015-2020)
8.2 Middle East & Africa Biological API Drug Manufacturing Consumption by Type
8.3 Middle East & Africa Biological API Drug Manufacturing Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biological API Drug Manufacturing Distributors
10.3 Biological API Drug Manufacturing Customer

11 Global Biological API Drug Manufacturing Market Forecast
11.1 Global Biological API Drug Manufacturing Consumption Forecast (2021-2025)
11.2 Global Biological API Drug Manufacturing Forecast by Regions
11.2.1 Global Biological API Drug Manufacturing Forecast by Regions (2021-2025)
11.2.2 Global Biological API Drug Manufacturing Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biological API Drug Manufacturing Forecast by Type
11.8 Global Biological API Drug Manufacturing Forecast by Application

12 Key Players Analysis
12.1 Lonza
12.1.1 Company Information
12.1.2 Biological API Drug Manufacturing Product Offered
12.1.3 Lonza Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Lonza Latest Developments
12.2 CEPiA Sanofi
12.2.1 Company Information
12.2.2 Biological API Drug Manufacturing Product Offered
12.2.3 CEPiA Sanofi Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CEPiA Sanofi Latest Developments
12.3 Boehringer Ingelheim BioXcellence
12.3.1 Company Information
12.3.2 Biological API Drug Manufacturing Product Offered
12.3.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Boehringer Ingelheim BioXcellence Latest Developments
12.4 DSM
12.4.1 Company Information
12.4.2 Biological API Drug Manufacturing Product Offered
12.4.3 DSM Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 DSM Latest Developments
12.5 Samsung BioLogics
12.5.1 Company Information
12.5.2 Biological API Drug Manufacturing Product Offered
12.5.3 Samsung BioLogics Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Samsung BioLogics Latest Developments
12.6 Celltrion
12.6.1 Company Information
12.6.2 Biological API Drug Manufacturing Product Offered
12.6.3 Celltrion Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Celltrion Latest Developments
12.7 AbbVie
12.7.1 Company Information
12.7.2 Biological API Drug Manufacturing Product Offered
12.7.3 AbbVie Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 AbbVie Latest Developments
12.8 Fujifilm Diosynth Biotechnologies
12.8.1 Company Information
12.8.2 Biological API Drug Manufacturing Product Offered
12.8.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Fujifilm Diosynth Biotechnologies Latest Developments
12.9 Baxter
12.9.1 Company Information
12.9.2 Biological API Drug Manufacturing Product Offered
12.9.3 Baxter Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Baxter Latest Developments
12.10 Cytovance Biologics
12.10.1 Company Information
12.10.2 Biological API Drug Manufacturing Product Offered
12.10.3 Cytovance Biologics Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Cytovance Biologics Latest Developments
12.11 GSK
12.11.1 Company Information
12.11.2 Biological API Drug Manufacturing Product Offered
12.11.3 GSK Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GSK Latest Developments
12.12 Vetter
12.12.1 Company Information
12.12.2 Biological API Drug Manufacturing Product Offered
12.12.3 Vetter Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Vetter Latest Developments
12.13 Sandoz
12.13.1 Company Information
12.13.2 Biological API Drug Manufacturing Product Offered
12.13.3 Sandoz Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Sandoz Latest Developments
12.14 Wuxi Biologics
12.14.1 Company Information
12.14.2 Biological API Drug Manufacturing Product Offered
12.14.3 Wuxi Biologics Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Wuxi Biologics Latest Developments
12.15 Pfizer CentreOne
12.15.1 Company Information
12.15.2 Biological API Drug Manufacturing Product Offered
12.15.3 Pfizer CentreOne Biological API Drug Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Pfizer CentreOne Latest Developments

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の生物学的API医薬品製造市場2020-2025:社内製造、受託製造(Global Biological API Drug Manufacturing Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。